Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C

Hepatology

Volumn 27, Issue 6, 1998, Pages 1695-1699

  Smith, Belinda C ^a   Grove, Jane ^a   Guzail, Muna A ^a   Day, Christopher P ^a   Daly, Ann K ^a   Burt, Alastair D ^a   Bassendine, Margaret F ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FERRITIN; IRON; VIRUS RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FERRITIN BLOOD LEVEL; GENE AMPLIFICATION; GENE MUTATION; HEMOCHROMATOSIS; HEPATITIS C; HETEROZYGOSITY; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IRON STORAGE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT;

ADULT; FEMALE; HEMOCHROMATOSIS; HEPATITIS C, CHRONIC; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION;

EID: 0031801787     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270631     Document Type: Article

References (21)

1. Tremolada F, Casarin C, Alberti A, Drago C, Tagger A, Ribero M, Realdi G. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol 1992;16:272-281.
2. Di Bisceglie A, Goodman Z, Ishak K, Hoofnagle J, Melpolder J, Alter H. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. HEPATOLOGY 1991;14:969-974.
3. Tong M, El-Farra N, Reikes A, Co R. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-1466.
4. Piperno A, D'Alba R, Fargion S, Roffi L, Sampietro M, Parma S, Arosio V, et al. Liver iron concentration in chronic viral hepatitis: a study of 98 patients. Eur J Gastroenterol Hepatol 1995;7:1203-1208.
5. Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 1995;22:449-456.
6. Di Bisceglie AM, Axiotis CA, Hoofnagle J, Bacon B. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992;102:2108-2113.
7. Van Thiel DH, Friedlander L, Fagiuoli S, Wright HI, Irish W, Gavaler JS. Response to interferon alpha therapy is influenced by the iron content of the liver. J Hepatol 1994;20:410-415.
8. Olynyk JK, Reddy K, Di Bisceglie AM, Jeffers L, Parker TI, Radick JL, Schiff ER, et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995;108:1104-1109.
9. Hayashi H, Takikawa T, Nishimura N, Yano M. Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C. J Hepatol 1995;22:268-271.
10. Blumberg BS, Lustbader ED, Whilford PL. Changes in serum iron levels due to infection with hepatitis B virus. Proc Natl Acad Sci USA 1981;78:3222-3224.
11. Caraceni P, Fagiuoli S, Van Thiel D. Iron reduction therapy: simply camouflage, or a real weapon. Am J Gastroenterol 1994;89:970-972.
12. Deugnier Y, Battistelli D, Jouanolle H, Guyader D, Gueguen M, Loreal O, Jacq̈uelinet C, et al. Hepatitis B virus infection markers in genetic haemochromatosis. J Hepatol 1991;13:286-290.
13. Weinberg E. Iron withholding: a defense against infection and neoplasia. Physiol Rev 1984;1984:65-102.
14. Piperno A, Fargion S, D'Alba R, Roffi L, Fracanzani A, Vecchi L, Failla M, et al. Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection. J Hepatol 1992;16:364-368.
15. Bodmer J, Parham P, Albert E, Marsh S. Putting a hold on "HLA-H." Nat Genet 1997;15:234-235.
16. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy D, Basava A, Dormishian F, et al. A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
17. Jouanolle AM, Gandon G, Jezequel P, Blayau M, Campion ML, Yaouanq J, Brittenham GM. Haemochromatosis and HLA-H. Nat Gen 1996;14:251-252.
18. Consortium UH. A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 1997;41:841-844.
19. Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, Morris CP, et al. Haemochromatosis and HLA-H. Nat Gen 1996;14:249-251.
20. Roberts A, Whatley S, Morgan R, Worwood M, Elder G. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997;349:321-323.
21. Roberts A, Whatley S, Nicklin S, Worwood M, Pointon J, Stone C, Elder GH. The frequency of haemochromatosis-associated alleles is increased in British patients with sporadic porphyria cutanea tarda. HEPATOLOGY 1997;25:159-161.